Open | 0.20 |
Previous Close | 0.206 |
Day Range | 0.20 - 0.21 |
52-Week Range | 0.20 - 1.65 |
All-Time High | 21.57 |
Avg. Volume (50-day) | 1,514,354.8 |
EPS (TTM) | -0.2894 |
Next Earnings Date | 2025-05-15 (BMO) |
Last Earnings Date | 2025-03-20 |
Forward Annual Dividend (Yield) | - |
Trailing Annual Dividend (Yield) | - |
Options | Yes |
P/E Ratio | -0.7100 |
PEG Ratio | - |
Price to Book | 4.45 |
Price to Cash Flow | - |
Price to Free Cash Flow | - |
Total Sales (TTM) | 178.56 M |
Revenue per Share (TTM) | 0.70 |
Shares Outstanding | 255.942 M |
Share Float (%) | 226.52 M |
% Held by Institutions | 37.39 |
Dividends Per Share (TTM) | - |
Ex-Dividend Date | - |
+/- EMA(20) | 0.35 (-43.71%) |
+/- SMA(50) | 0.5 (-60.60%) |
+/- SMA(200) | 0.81 (-75.68%) |
5-Day Perf. | -28.83% |
1-Month Perf. | -63.52% |
3-Month Perf. | -63.43% |
6-Month Perf. | -79.27% |
YTD Perf. | -63.43% |
1-Year Perf. | -87.53% |
RSI(14) | 13.59 |
ATR(14) | 0.04 |
ADX(14) | 41.5 |
Beta (5Y) | 1.27 |
As a StockCharts Member, you can review earnings results and analyze revenue and earnings growth over time. Bring a balance of technicals and fundamentals to your approach when you join today!
Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom.
ADAP has triggered the following predefined scans:
P&F Double Bottom Breakdown |
P&F Descending Triple Bottom Breakdown |
New 52-week Lows |
As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.
As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.